SCHEMBL23309497

SCHEMBL23309497

COc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.57
▸ MEN1 O00255 3/20 0.52
▸ NPC1 O15118 3/20 0.51
▸ RAB9A P51151 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ PDE4B Q07343 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ GRM4 Q14833 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ MAOA P21397 1/20 0.50
▸ MAOB P27338 1/20 0.50
▸ MAPK1 P28482 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309711 0.90 GRM4 (0.53) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309480 0.86 ALDH1A1 (0.53) KMT2AMEN1ALDH1A1SMN1; SMN2TP53
SCHEMBL23309617 0.84 NPC1 (0.54) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309730 0.83 KMT2A (0.47) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309513 0.81 RAB9A (0.63) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309477 0.80 ATF1 (0.51) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309483 0.80 CYP1A2 (0.52) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309703 0.80 RAB9A (0.51) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309621 0.80 RAB9A (0.50) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23309533 0.79 ALDH1A1 (0.43) KMT2ANPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL KMT2A 2360/4885MEN1 1633/4885NPC1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback